The history of Viagra offers a intriguing case study for pharmaceutical stakeholders. Initially a phenomenal success, producing billions in profits, the patent end has revealed the problems of relying on a single product. While alternative versions have significantly eroded sales , questions remain about the overall outlook of firms heavily investe

The neon lights of Sin City have always been synonymous with risk, but lately, a new kind of gamble has taken center stage: copyright. With Bitcoin and Ethereum prices soaring to dizzying heights, a wave of investors are flocking to the desert metropolis, hoping to strike it rich. Fueling this frenzy is an unlikely marriage between the world-famous